Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026

Go back to Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026
(NASDAQ: CRBU) Delayed: 1.64 --0 (-0%)
Previous Close $1.64    52 Week High
Open $1.63    52 Week Low
Day High $1.69    P/E N/A 
Day Low $1.62    EPS
Volume 604,161